Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Memantine to Preserve Memory and Neurocognition Following Craniospinal Irradiation- A Randomised Controlled Trial (MEMENTO)

NCT06275035 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT06275035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06275035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Memantine to Preserve Memory and Neurocognition Following Craniospinal Irradiation- A Randomised Controlled Trial (MEMENTO)
Lead sponsor
Tata Memorial Centre
Phase
Phase 3
Overall status
Recruiting
Start date
February 22, 2024
Completion date
January 31, 2031
Enrollment
101 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurocognitive dysfunction